Application

NUQUANT

Tecan Genomics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97178464
Filing Date: 12/17/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97178464
MARK INFORMATION
*MARK NUQUANT
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT NUQUANT
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Tecan Genomics, Inc.
*MAILING ADDRESS 900 Chesapeake Drive
*CITY Redwood City
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94063
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 001 
*IDENTIFICATION Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for scientific or research purposes, in particular for use in genomic research; Biochemical reagents for scientific or research purposes, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for scientific or research purposes, in particular for measuring molarity of libraries for sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use in laboratory or research clinical nucleic acid-based diagnostics
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 005 
*IDENTIFICATION Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for measuring molarity of libraries for sequencing
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Peter J. Willsey
ATTORNEY DOCKET NUMBER 34079/553
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Brown Rudnick LLP
STREET 601 Thirteenth Street NW Suite 600
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20005
PHONE 202-536-1751
FAX 617-289-0851
EMAIL ADDRESS trademarks@brownrudnick.com
OTHER APPOINTED ATTORNEY Vincent J. Badolato, Jason M. Sobel, Ian G. DiBernardo, Robert J. Tosti and Alvin B. Carter III
CORRESPONDENCE INFORMATION
NAME Peter J. Willsey
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@brownrudnick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) pwillsey@brownrudnick.com; doakes@brownrudnick.com; cftergiotis@brownrudnick.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE /Leonard J. Goren/
SIGNATORY'S NAME Leonard J. Goren
SIGNATORY'S POSITION General Manager
SIGNATORY'S PHONE NUMBER 1-650-590-3660
DATE SIGNED 12/17/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97178464
Filing Date: 12/17/2021

To the Commissioner for Trademarks:

MARK: NUQUANT (Standard Characters, see mark)
The literal element of the mark consists of NUQUANT. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Tecan Genomics, Inc., a corporation of Delaware, having an address of
      900 Chesapeake Drive
      Redwood City, California 94063
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 001:  Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for scientific or research purposes, in particular for use in genomic research; Biochemical reagents for scientific or research purposes, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for scientific or research purposes, in particular for measuring molarity of libraries for sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use in laboratory or research clinical nucleic acid-based diagnostics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 005:  Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for measuring molarity of libraries for sequencing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Peter J. Willsey. Other appointed attorneys are Vincent J. Badolato, Jason M. Sobel, Ian G. DiBernardo, Robert J. Tosti and Alvin B. Carter III. Peter J. Willsey of Brown Rudnick LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      601 Thirteenth Street NW Suite 600
      Washington, District of Columbia 20005
      United States
      202-536-1751(phone)
      617-289-0851(fax)
      trademarks@brownrudnick.com
The docket/reference number is 34079/553.
Peter J. Willsey submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Peter J. Willsey
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@brownrudnick.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): pwillsey@brownrudnick.com; doakes@brownrudnick.com; cftergiotis@brownrudnick.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Leonard J. Goren/   Date: 12/17/2021
Signatory's Name: Leonard J. Goren
Signatory's Position: General Manager
Signatory's Phone Number: 1-650-590-3660
Signature method: Sent to third party for signature
Payment Sale Number: 97178464
Payment Accounting Date: 12/17/2021

Serial Number: 97178464
Internet Transmission Date: Fri Dec 17 17:25:43 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.X.XX-202112171725430775
68-97178464-781cbf6a651ea8d4adff69c8ea39
5bbb2ed183b28b53258bf27ac1559b7e27a5-DA-
25421925-20211217152644980099

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed